Skip to main content

Amarin Corp PLC

AMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000897448

No open-market purchases or sales by Amarin Corp PLC insiders were filed in the last 90 days; 80 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Amarin Corp PLC changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of AMRN: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders91182−8
Shares4.00M13.7K4.54M+547.3K (+13.7%)
Value$65.8M$224.4K$63.6M−$2.05M (−3.1%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Amarin Corp PLC at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to AMRN in Q4 2025
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.36,491$509.2K0.00%
XTX Topco Ltd17,124$239.0K0.01%
EntryPoint Capital, LLC12,542$175.0K0.07%
Estate Planners Group, LLC500$6.98K0.00%
Simplex Trading, LLC494$6.89K0.00%
Huntington National Bank100$1.40K0.00%
SageView Advisory Group, LLC19$2660.00%
Keating Financial Advisory Services, Inc.15$2090.00%
McGuire Capital Advisors Inc7$980.00%
Brooklands Fund Management Ltd2,994––

Sold out (18)

Institutions that held Amarin Corp PLC at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (1)

Institutions that held Amarin Corp PLC at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AMRN in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Cubist Systematic Strategies, LLC13,699$224.4K